What is Alloy Therapeutics worth?
$1.0Blast known valuation
Alloy Therapeutics last raised $30.0M in its Early Stage VC (Mar 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Alloy Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2026 | Early Stage VC | $30.0M | ▮ | ▮ |
| Sep 2022 | Early Stage VC | $41.7M | ▮ | ▮ |
| Mar 2021 | Later Stage VC | $75.0M | ▮ | ▮ |
How Alloy Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Alloy Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Alloy Therapeutics worth?
- Alloy Therapeutics's last known valuation is $1.0B.
- How much has Alloy Therapeutics raised?
- Alloy Therapeutics has raised $174.0M in total funding across 3 recorded rounds.
- When did Alloy Therapeutics last raise?
- Alloy Therapeutics last raised in Mar 2026 (Early Stage VC), raising $30.0M.